Breath Test Detects Blood Sugar | Diabetes Monitoring Tech

LONDON – For patients with type 1 diabetes (T1D), hypoglycemia can lead to serious complications. Researchers at Imperial College London and the university of Oxford are developing a non-invasive blood sugar monitoring system that analyzes exhaled breath to predict hypoglycemic states, possibly eliminating the need for finger pricks or continuous glucose monitors.

The research, published in Scientific Reports, utilizes “breath metabolomics” to analyze volatile organic compounds (VOCs) in exhaled breath. These trace gases, by-products of cell metabolism, can indicate specific metabolic states, including hypoglycemia.

Decoding Body State with Odor: Exhale Metabolites

Different physiological states produce unique VOC combinations. During fasting or hypoglycemia, the body burns fat for energy, producing ketones and aldehydes.While undetectable by human smell, these molecules can be accurately analyzed using gas chromatography-mass spectrometry (GC-MS).

Summer Camp Samples

The research team collected exhaled breath samples from T1D children aged 6 to 18 at British Diabetes summer camps. Samples where taken every few hours, alongside continuous blood glucose data, resulting in over 500 expiratory samples and corresponding blood sugar readings for VOC analysis.

Preliminary results suggest that while single VOC samples aren’t definitive, continuous observation combined with machine learning algorithms can predict hypoglycemia with over 90% accuracy. This indicates the potential of breath analysis combined with AI.

Smart Masks and Metabolic Research

This technology has two potential commercial applications. first, integration into a smart mask or breath sensor could provide immediate warnings of hypoglycemia, acting as a life-saving device for patients with asymptomatic hypoglycemia. Second, the research offers new insights into the metabolic characteristics of T1D. Analyzing expiratory metabolites could clarify differences in energy metabolism between T1D and type 2 diabetes (T2D),potentially leading to new treatment strategies.

Why Type 1 Diabetes?

While T2D is more prevalent, this study focused on T1D because these patients rely on insulin injections, making them more prone to acute hypoglycemic events. Additionally, T1D patients are often younger and metabolically active, making metabolic changes easier to recognize.expanding the study to T2D patients could further refine the understanding of expiratory characteristics across different diabetes types.

this study represents a significant shift towards non-invasive diabetes care, offering the hope of a future without finger pricks. Challenges remain, including VOC sensing stability, device portability, and individual variability. However, this research has opened a promising new avenue for diabetes management.

(First picture source: shutterstock)